Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: Rapid response to treatment with rituximab

Journal of Clinical Virology

Volumn 47, Issue 1, 2010, Pages 69-71

  Uppal, Richa ^a   Charles, Edgar ^b   Lake Bakaar, Gerond ^b  

^a NEW YORK DOWNTOWN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Hepatitis C; Mononeuritis multiplex; Rituximab; Type II mixed cryoglobulinemia

Indexed keywords

RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRYOGLOBULINEMIA; DEPRESSION; ERECTILE DYSFUNCTION; FOOT DISEASE; FOOT DROP; HEPATITIS C VIRUS; HUMAN; MALE; MONONEUROPATHY MULTIPLEX; PRIORITY JOURNAL; VASCULITIC RASH; WRIST DISEASE; WRIST DROP;

ANTIBODIES, MONOCLONAL; CRYOGLOBULINEMIA; GAIT DISORDERS, NEUROLOGIC; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOLOGIC FACTORS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RADIAL NEUROPATHY;

EID: 72049123264     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.10.006     Document Type: Article

References (21)

1. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 19 1 (1997) 111-129
2. Dammacco F., and Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 87 March (3) (1992) 352-356
3. Lidove O., Cacoub P., Maisonobe T., Servan J., Thibault V., Piette J.C., et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis 60 March (3) (2001) 290-292
4. Lidove O., Maisonobe T., Servan J., Thibault V., Leger J.M., Piette J.C., et al. Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia. La Revue de medecine interne/fondee 22 October (10) (2001) 939-947
5. Leandro M.J., Cambridge G., Ehrenstein M.R., and Edwards J.C. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 54 February (2) (2006) 613-620
6. Lamprecht P., Lerin-Lozano C., Merz H., Dennin R.H., Gause A., Voswinkel J., et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 62 December (12) (2003) 1230-1233
7. Cacoub P., Delluc A., Saadoun D., Landau D.A., and Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?. Ann Rheum Dis 67 March (3) (2008) 283-287
8. Pestronk A., Florence J., Miller T., Choksi R., Al-Lozi M.T., and Levine T.D. Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry 74 April (4) (2003) 485-489
9. Lake-Bakaar G., Dustin L., McKeating J., Newton K., Freeman V., and Frost S.D. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood 109 January (2) (2007) 845-846
10. Sansonno D., De Re V., Lauletta G., Tucci F.A., Boiocchi M., and Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101 June (10) (2003) 3818-3826
11. Hardy R.R. B-1 B cell development. J Immunol 177 September (5) (2006) 2749-2754
12. Jones D., Benjamin R.J., Shahsafaei A., and Dorfman D.M. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 95 January (2) (2000) 627-632
13. Bonetti B., Scardoni M., Monaco S., Rizzuto N., and Scarpa A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch 434 June (6) (1999) 533-535
14. Itoh K., Tanaka H., Shiga J., Hirakawa K., Akahane Y., Tsuda F., et al. Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors. Am J Gastroenterol 89 November (11) (1994) 2019-2024
15. Carson C.W., Conn D.L., Czaja A.J., Wright T.L., and Brecher M.E. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 20 February (2) (1993) 304-309
16. Plosker G.L., and Figgitt D.P. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 63 8 (2003) 803-843
17. Knapp M.J., and Colburn P.A. Clinical uses of intravenous immune globulin. Clin Pharm 9 7 (1990 Jul) 509-529
18. Anolik J.H., Friedberg J.W., Zheng B., Barnard J., Owen T., Cushing E., et al. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol 122 February (2) (2007) 139-145
19. Vallerskog T., Gunnarsson I., Widhe M., Risselada A., Klareskog L., van Vollenhoven R., et al. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122 January (1) (2007) 62-74
20. Linton P.J., Harbertson J., and Bradley L.M. A critical role for B cells in the development of memory CD4 cells. J Immunol 165 December (10) (2000) 5558-5565
21. Lake-Bakaar G, Tsang P. Controlling B-cell activating factor (BAFF/BLyS) levels in chronic hepatitis C virus infection. DDW; 2008.